Metirox-5 Tablet

About Metirox-5 Tablet

Metirox-5 is a 5 mg tablet containing methimazole, an anti-thyroid medicine. It is used in people with an overactive thyroid when surgery or radioactive iodine is not suitable, or to ease symptoms before such treatment.

There are 5 brands of Methimazole listed in Bangladesh.

What is Metirox-5 Tablet?

Metirox-5 is a tablet made by Renata PLC. It contains methimazole 5 mg, which belongs to a group of medicines called anti-thyroid drugs. It works by reducing the amount of thyroid hormone the body makes. It does not change thyroid hormone that is already stored in the body or in the blood. Metirox-5 is used for adults with Graves' disease or toxic multinodular goiter when surgery or radioactive iodine is not an appropriate option. It is also used to relieve symptoms of hyperthyroidism while preparing for thyroid surgery or radioactive iodine treatment. The dose and course are decided by the doctor.

Uses of Metirox-5

Metirox-5 is used to treat an overactive thyroid (hyperthyroidism) in people with Graves' disease or toxic multinodular goiter, when surgery or radioactive iodine therapy is not suitable. It is also used to reduce symptoms of hyperthyroidism before thyroidectomy or radioactive iodine therapy. It lowers the production of thyroid hormones but does not affect thyroid hormones already present in the body or given as medicine. Only a doctor can decide if it is right for a particular person.

How to use Metirox-5

Metirox-5 is taken by mouth. The doctor decides the dose, how often to take it, and how long the course lasts. Swallow the tablet with water, with or without food, unless the doctor advises otherwise. Do not change the dose or stop taking it without talking to the doctor. Keep all appointments for blood tests, because the doctor uses them to adjust the dose. If you miss a dose, ask the doctor or pharmacist what to do. Store the tablets in a cool, dry place below 30°C, away from light and children.

Side effects of Metirox-5

Common side effects include skin rash, itching, nausea, vomiting, stomach discomfort, joint or muscle pain, tingling, headache, drowsiness, dizziness, loss of taste, and hair loss. Some people may have jaundice (yellowing of skin or eyes) or enlarged lymph nodes. Rare but serious effects include low white blood cell counts, low platelet counts, anaemia, liver problems, fever, and a lupus-like reaction. Tell the doctor promptly about fever, sore throat, mouth ulcers, unusual bruising, yellowing of the skin, or severe stomach pain.

Safety and precautions

Metirox-5 must not be used by anyone allergic to methimazole or any other ingredient in the tablet. It can harm an unborn baby, especially in the first trimester, so pregnant women or those planning pregnancy should tell the doctor before starting it; other treatment may be considered. It passes into breast milk, so breastfeeding mothers should ask the doctor first. People with liver problems or blood disorders should also check with the doctor. The doctor will decide the dose and may arrange regular blood tests. Keep all appointments and report new symptoms.

Frequently asked questions

What does the generic name methimazole mean?

Methimazole is the active ingredient in Metirox-5. It is the generic name of an anti-thyroid medicine that reduces the amount of thyroid hormone the body makes. It does not change thyroid hormone already stored in the body or taken as medicine.

What is Metirox-5 used for and what kind of medicine is it?

Metirox-5 is an anti-thyroid tablet containing methimazole 5 mg. It is used for an overactive thyroid in Graves' disease or toxic multinodular goiter when surgery or radioactive iodine is not suitable, and to ease symptoms before thyroid surgery or radioactive iodine therapy.

Who should avoid Metirox-5 or ask the doctor first?

Do not take it if you are allergic to methimazole or any ingredient. Ask the doctor first if you are pregnant, planning pregnancy, or breastfeeding, or if you have liver or blood problems. The doctor will decide if it is suitable and how to monitor you.

Can I stop taking Metirox-5 on my own?

No. Stopping suddenly or changing the dose without medical advice can affect your thyroid control. The doctor decides the dose and course and may adjust it based on blood tests. Talk to your doctor before making any change, and keep all follow-up appointments.

Indications

Methimazole is indicated:
  • In patients with Graves' disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option.
  • To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.

Pharmacology

Methimazole inhibits the synthesis of thyroid hormones and thus is effective in the treatment of hyperthyroidism. The drug does not inactivate existing thyroxine and triiodothyronine that are stored in the thyroid or circulating in the blood nor does it interfere with the effectiveness of thyroid hormones given by mouth or by injection. Methimazole is readily absorbed in the gastrointestinal tract, metabolized in the liver, and excreted in the urine.

Dosage & Administration

Methimazole is administered orally. The total daily dosage is usually given in 3 divided doses at approximately 8 hour intervals.

Adults: The initial daily dosage is 15 mg for mild hyperthyroidism, 30 to 40 mg for moderately severe hyperthyroidism, and 60 mg for severe hyperthyroidism, divided into 3 doses at 8 hour intervals. The maintenance dosage is 5 to 15 mg daily.

Pediatric: Initially, the daily dosage is 0.4 mg/kg of body weight divided into 3 doses and given at 8 hour intervals. The maintenance dosage is approximately 1/2 of the initial dose.

Use in children & adolescents: Because of post-marketing reports of severe liver injury in pediatric patient treated with propylthiouracil, Methimazole is the preferred choice when an antithyroid drug is required for a pediatric patient.

Interaction

With medicine: Anticoagulants (oral)- Due to potential inhibition of vitamin K activity by methimazole, the activity of oral anticoagulants (e.g., warfarin) may be increased; additional monitoring of PT/INR should be considered, especially before surgical procedures. β-adrenergic blocking agents- Hyperthyroidism may cause an increased clearance of beta-blockers with a high extraction ratio. A dose reduction of beta-adrenergic blockers may be needed when a hyperthyroid patient becomes euthyroid. Digitalis glycosides- Serum digitalis levels may be increased when hyperthyroid patients on a stable digitalis glycoside regimen become euthyroid; a reduced dosage of digitalis glycosides may be needed. Theophylline- Theophylline clearance may decrease when hyperthyroid patients on a stable theophylline regimen become euthyroid; a reduced dose of theophylline may be needed.

With food: Always take at the same moment in regard to meals, food may affect absorption unpredictably.

Contraindications

Methimazole is contraindicated in the presence of hypersensitivity to the drug or any of the other product components.

Side Effects

Common: Skin rash, urticaria, nausea, vomiting, epigastric distress, arthralgia, paresthesia, loss of taste, abnormal loss of hair, myalgia, headache, pruritus, drowsiness, neuritis, edema, vertigo, skin pigmentation, jaundice, sialadenopathy, and lymphadenopathy.

Rare: Agranulocytosis, granulocytopenia, thrombocytopenia and aplastic anemia, drug fever, a lupus-like syndrome, insulin autoimmune syndrome (which can result in hypoglycemic coma), hepatitis (jaundice may persist for several weeks after discontinuation of the drug), periarteritis, and hypoprothrombinemia. Nephritis occurs very rarely.

Pregnancy & Lactation

Pregnancy Category D. Due to the rare occurrence of congenital malformations associated with methimazole use, it may be appropriate to use other agents in pregnant women requiring treatment for hyperthyroidism particularly in the first trimester of pregnancy. Methimazole is excreted into breast milk. However, several studies found no effect on clinical status in nursing infants of mothers taking methimazole, particularly if thyroid function is monitored at frequent (weekly or biweekly) intervals.

Precautions & Warnings

Congenital Malformations: Methimazole readily crosses the placental membranes and can cause fetal harm, particularly when administered in the first trimester of pregnancy. If Methimazole is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be warned of the potential hazard to the fetus. Since some congenital defects have been reported in offspring of patients treated with Methimazole, it may be appropriate to use other agents in pregnant women requiring treatment for hyperthyroidism, particularly in the first trimester of pregnancy. If Methimazole is used, the lowest possible dose to control the disease should be given.

Agranulocytosis: Agranulocytosis is potentially a life-threatening adverse reaction of Methimazole therapy. Patients should be instructed to immediately report to their physicians if any symptoms suggestive of agranulocytosis, such as fever or sore throat occur. Leukopenia, thrombocytopenia, and aplastic anemia (pancytopenia) may also occur. The drug should be discontinued in the presence of agranulocytosis, aplastic anemia (pancytopenia), ANCA-positive vasculitis, hepatitis, or exfoliative dermatitis and the patient’s bone marrow indices should be monitored.

Liver Toxicity: Although there have been reports of hepatotoxicity associated with Methimazole, the risk of hepatotoxicity appears to be less with methimazole than with propylthiouracil, especially in the pediatric population. Drug treatment should be discontinued promptly in the event of clinically significant evidence of liver abnormality including hepatic transaminase values exceeding 3 times the upper limit of normal.

Hypothyroidism: Methimazole can cause hypothyroidism necessitating routine monitoring of TSH and free T4 levels with adjustments in dosing to maintain a euthyroid state. Because the drug readily crosses placental membranes, Methimazole can cause fetal goiter and cretinism when administered to a pregnant woman. For this reason, it is important that a sufficient, but not excessive, dose be given during pregnancy. Because Methimazole may cause hypoprothrombinemia and bleeding, prothrombin time should be monitored during therapy with the drug, especially before surgical procedures. Thyroid function tests should be monitored periodically during therapy. Once clinical evidence of hyperthyroidism has resolved, the finding of a rising serum TSH indicates that a lower maintenance dose of Methimazole should be employed.

Overdose Effects

Symptoms may include nausea, vomiting, epigastric distress, headache, fever, joint pain, pruritus, and edema. Aplastic anemia or agranulocytosis may be manifested in hours to days. Less frequent events are hepatitis, nephrotic syndrome, exfoliative dermatitis, neuropathies, and CNS stimulation or depression. In the event of an overdose, appropriate supportive treatment should be initiated as dictated by the patient’s medical status.

Storage Conditions

Store in a cool (below 30°C) and dry place, away from light and children.

Alternative brands of Methimazole

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.